HRTISHerantis Pharma OyjHRTIS info
$1.57info-2.08%24h
Global rank27729
Market cap$31.60M
Change 7d-11.88%
YTD Performance-10.48%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Herantis Pharma Oyj (HRTIS) Stock Overview

    Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic molecule developed based on the active site of the parent CDNF protein for the treatment of PD and other neurodegenerative diseases; and recombinant human CDNF protein. The company was incorporated in 2008 and is based in Espoo, Finland.

    HRTIS Stock Information

    Symbol
    HRTIS
    Address
    Bertel Jungin Aukio 1Espoo, 02600Finland
    Founded
    -
    Trading hours
    -
    Website
    https://herantis.com
    Country
    🇫🇮 Finland
    Phone Number
    358 9222 1195

    Herantis Pharma Oyj (HRTIS) Price Chart

    -
    Value:-

    Herantis Pharma Oyj Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.57
    N/A
    Market Cap
    $31.60M
    N/A
    Shares Outstanding
    20.16M
    N/A
    Employees
    10.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org